ADXNAddex Therapeutics LtdSep 28, 2026Q2 2026
Read transcript →Addex Therapeutics Ltd (ADXN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.85
-1.72%
Mkt Cap $4.76M
ADXNAddex Therapeutics LtdSep 28, 2026ADXNAddex Therapeutics LtdJun 25, 2026Q1 2026
Read transcript →ADXNAddex Therapeutics LtdDec 4, 2025Q3 2025
Read transcript →ADXNAddex Therapeutics LtdOct 1, 2025Q2 2025
Read transcript →ADXNAddex Therapeutics LtdJun 19, 2025Q1 2025
Read transcript →ADXNAddex Therapeutics LtdApr 25, 2025Q4 2024
Read transcript →ADXNAddex Therapeutics LtdNov 22, 2024Q3 2024
Read transcript →ADXNAddex Therapeutics LtdSep 30, 2024Q2 2024
Read transcript →ADXNAddex Therapeutics LtdJun 6, 2024Q1 2024
Read transcript →ADXNAddex Therapeutics LtdApr 18, 2024Q4 2023
Read transcript →ADXNAddex Therapeutics LtdNov 29, 2023Q3 2023
Read transcript →ADXNAddex Therapeutics LtdAug 10, 2023Q2 2023
Read transcript →ADXNAddex Therapeutics LtdMay 12, 2023Q1 2023
Read transcript →ADXNAddex Therapeutics LtdMar 31, 2023Q4 2022
Read transcript →ADXNAddex Therapeutics LtdNov 11, 2022Q3 2022
Read transcript →ADXNAddex Therapeutics LtdAug 18, 2022Q2 2022
Read transcript →ADXNAddex Therapeutics LtdMar 10, 2022Q4 2021
Read transcript →ADXNAddex Therapeutics LtdNov 4, 2021Q3 2021
Read transcript →ADXNAddex Therapeutics LtdMar 11, 2021Q4 2020
Read transcript →